Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe IgE-mediated Asthma”

4 trials

Showing 4 of 4 results

Large-scale testing (Phase 3)Study completedNCT00671268
What this trial is testing

Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma

Who this might be right for
Rhinoconjunctivitis
Allergopharma GmbH & Co. KG 256
Post-approval studies (Phase 4)Ended earlyNCT01912872
What this trial is testing

Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma

Who this might be right for
Severe IgE-mediated Asthma
Novartis Pharmaceuticals 112
Testing effectiveness (Phase 2)Study completedNCT00666341
What this trial is testing

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Who this might be right for
Type I-Allergy
Allergopharma GmbH & Co. KG 50
Large-scale testing (Phase 3)Study completedNCT01007149
What this trial is testing

Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 79

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation